2011 | |
---|---|
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
2008 | |
Criterium: | Position: |
Overall Score: | > 1000 |
Networking Rank (Reputation): | > 1000 |
Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2013 | 0 | 5.987.700 | 651.750 | 1 | ||
2012 | 0 | 1.667.076 | 553.879 | 1 | ||
2011 | 0 | 4.363.380 | 1.209.000 | 1 |
Total number of partners: 18
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 18
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2013-09-01 | Targeting novel lipid pathways for treatment of cardiovascular disease | ATHERO-FLUX | participant | 5.987.700 | 11 |
2012-01-01 | Development of microRNA Medicines for Cardiac Metabolic Diseases; A Targeted European Exchange Programme | CardiomiR | participant | 1.667.076 | 4 |
2011-10-01 | Micropattern-Enhanced High Throughput RNA Interference for Cell Screening | MEHTRICS | participant | 4.363.380 | 6 |